Fish oil n-3 fatty acids increase adiponectin and decrease leptin levels in patients with systemic lupus erythematosus

Marine Drugs

Volumn 13, Issue 2, 2015, Pages 1071-1083

  Lozovoy, Marcell Alysson Batisti ^a   Simão, Andréa Name Colado ^a   Morimoto, Helena Kaminami ^a   Scavuzzi, Bruna Miglioranza ^a   Iriyoda, Tathiana Veiga Mayumi ^a   Reiche, Edna Maria Vissoci ^a   Cecchini, Rubens ^a   Dichi, Isaias ^a  

^a University Hospital of Londrina   (Brazil)

Author keywords

Adiponectin; Cardiovascular risk; Fish oil; Leptin; Systemic lupus erythematosus

Indexed keywords

ADIPONECTIN; LEPTIN; OMEGA 3 FATTY ACID; ADIPOQ PROTEIN, HUMAN; BIOLOGICAL MARKER; FISH OIL;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG MECHANISM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT DURATION; AGONISTS; ANTAGONISTS AND INHIBITORS; ANTHROPOMETRY; BLOOD PRESSURE; LUPUS ERYTHEMATOSUS, SYSTEMIC; METABOLISM; MIDDLE AGED;

ADIPONECTIN; ADULT; ANTHROPOMETRY; BIOMARKERS; BLOOD PRESSURE; FATTY ACIDS, OMEGA-3; FEMALE; FISH OILS; HUMANS; LEPTIN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84923261250     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md13021071     Document Type: Article

References (44)

1. Oates, J.C. The biology of reactive intermediates in systemic lupus erythematosus. Autoimmunity 2010, 43, 56-63; doi:10.3109/08916930903374683.
2. Bernatsky, S.; Boivin, J.F.; Joseph, J.E.; Manzi, S.; Ginzler, E.; Gladman, D.D.; Urowitz, M.; Fortin, P.R.; Petri, M.; Barr, S.; et al. Mortality in systemic lupus erythematosus. Arthritis Rheum. 2006, 54, 2550-2557; doi:10.1002/art.21955.
3. Asanuma, Y.; Oeser, A.; Shintani, A.K.; Turner, E.; Olsen, N.; Fazio, S.; Linton, M.F.; Raggi, P. Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N. Engl. J. Med. 2003, 349, 2407-2415; doi:10.1056/NEJMoa035611.
4. Ross, R. Atherosclerosis - An inflammatory disease. N. Engl. J. Med. 1999, 340, 115-126; doi:10.1056/NEJM199901143400207.
5. Tilg, H.; Moshen, A.R. Adipokines: Mediators linking adipose tissue, inflammation and immunity. Nat. Rev. Immunol. 2006, 6, 772-783; doi:10.1038/nri1937.
6. Belyosku, J. Leptin and atherosclerosis. Atherosclerosis 2006, 189, 47-60; doi:10.1016/j.atherosclerosis.2006.03.003.
7. Rothenbacher, D.; Brenner, H.; Marz, W.; Koenig, W. Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers. Eur. Heart J. 2005, 26, 1640-1646; doi:10.1093/eurheartj/ehi340.
8. Hashimoto, N.; Kanda, J.; Nakamura, T.; Horie, A.; Kurosawa, H.; Hashimoto, T.; Sato, K.; Suzuki, M.; Yano, S.; Iwai, R.; et al. Association of hypoadiponectinemia in men with early onset of coronary heart disease and multiple coronary artery stenoses. Metabolism 2006, 55, 1653-1657; doi:10.1016/j.metabol.2006.08.005.
9. Wallace, A.M.; McMahon, A.D.; Packard, C.J. Plasma leptin and the risk of cardiovascular disease in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation 2011, 104, 3052-3056; doi:10.1161/hc5001.101061.
10. Aprahamian, T.; Bonegio, R.G.; Richez, C.; Yasuda, K.; Chiang, L.K.; Sato, K.; Walsh, K.; Rifkin, I.R. The peroxisome proliferator-activated receptor γ agonist rosiglitazone ameliorates murine lupus by induction of adiponectin. J. Immunol. 2009, 182, 340-346; doi:10.4049/jimmunol.182.1.340.
11. Parker, J.; Menn-Josephy, H.; Laskow, B.; Takemura, Y.; Aprahamian, T. Modulation of lupus phenotype by adiponectin deficiency in autoimmune mouse models. J. Clin. Immunol. 2011, 31, 167-173; doi:10.1007/s10875-010-9486-2.
12. Banga, A.; Unal, R.; Tripathi, P.; Pokrovskaya, I.; Owens, R.J.; Kern, P.A.; Ranganathan, G. Adiponectin translation is increased by the PPARy agonists pioglitazone and ω-3 fatty acids. Am. J. Physiol. Endocrinol. Metab. 2009, 296, E480-E489; doi:10.1152/ajpendo.90892.2008.
13. Wislowska, M.; Rok, M.; Stepien, K.; Kuklo-Kowalska, A. Serum leptin levels in systemic lupus erythematosus. Rheumatol. Int. 2008, 28, 467-473; doi:10.1007/s00296-008-0526-7.
14. Winniki, M.; Somers, V.K.; Accurso, V. Fish-rich diet. Leptin, and body mass. Circulation 2002, 106, 289-291; doi:10.1161/01.CIR.0000025241.01418.4D.
15. Hochberg, M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997, 40, 1725; doi:10.1002/art.1780400928.
16. Berbert, A.A.; Kondo, C.R.M.; Almendra, C.L.; Matsuo, T.; Dichi, I. Supplementation of fish oil and olive oil in patients with rheumatoid arthritis. Nutrition 2005, 21, 131-136; doi:10.1016/j.nut.2004.03.023.
17. Pickering, T.G.; Hall, J.E.; Appel, L.J.; Falkner, B.E.; Graves, J.; Hill, M.N.; Jones, D.W.; Kurtz, T.; Sheps, S.G.; Roccella, E.J.; et al. Recommendations for Blood Pressure Measurement in Humans and Experimental Animals. Part 1: Blood Pressure Measurement in Humans: A Statement for Professionals From the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension 2005, 45, 142-161; doi:10.1161/01.CIR.0000154900.76284.F6.
18. Haffner, S.M.; Miettinen, H.; Stern, M.P. The homeostasis model in the San Antonio Heart Study. Diabetes Care 1997, 20, 1087-1092; doi:10.2337/diacare.20.7.1087.
19. Bombardier, C.; Gladman, D.D.; Urowitz, M.B.; Caron, D.; Chang, C.H. Derivation of the SLEDAI: A disease activity index for lupus patients. The Committee on prognosis Studies in SLE. Arthritis Rheum. 1992, 35, 630-640; doi:10.1002/art.1780350606.
20. Harris, W.S. N-3 Fatty acids and serum lipoproteins: Human studies. Am. J. Clin. Nutr. 1997, 65 (Suppl. S5), 1645-1654.
21. Jacobson, T.A. Role of n-3 fatty acids in the treatment of hypertriglyceridemia and cardiovascular disease. Am. J. Clin. Nutr. 2008, 87 (Suppl. S6), 1981-1990.
22. Harris, W.S.; Bulchandani, D. Why do ω-3 fatty acids lower serum triglycerides? Curr. Opin. Lipidol. 2006, 17, 387-393; doi:10.1097/01.mol.0000236363.63840.16.
23. Balk, E.M.; Lichtenstein, A.H.; Chung, M.; Kupelnick, B.; Chew, P.; Lau, J. Effects of ω-3 fatty acids on serum markers of cardiovascular disease risk: A systematic review. Atherosclerosis 2006, 189, 19-30; doi:10.1016/j.atherosclerosis.2006.02.012.
24. Chan, D.C.; Watts, G.F.; Barrett, P.H.R.; Beilin, L.J.; Redgrave, T.G.; Mori, T.A. Regulatory effects of HMG CoA reductase inhibitor and fish oils on apolipoprotein B-100 kinetics in insulin resistant obese male subjects with dyslipidemia. Diabetes 2002, 51, 2377-2386; doi:10.2337/diabetes.51.8.2377.
25. Simão, A.N.C.; Lozavoy, M.A.B.; Dichi, I. Effect of soy product kinako and fish oil on serum lipids and glucose metabolism in women with metabolic syndrome. Nutrition 2014, 30, 112-115; doi:10.1016/j.nut.2013.05.024.
26. Dichi, I.; Simão, A.N.C. Metabolic Syndrome: New Targets for an Old Problem. Expert Opin. Ther. Targets 2012, 16, 1-4; doi:10.1517/14728222.2012.648924.
27. Sada, K.-E.; Yamasaki, Y.; Maruyama, M.; Sugiyama, H.; Yamamura, M.; Maeshima, Y.; Makino, H. Altered levels of adipocytokines in association with insulin resistance in patients with systemic lupus erytheamtosus. J. Rheumatol. 2006, 33, 1545-1552.
28. De Sanctis, J.B.; Zabaleta, M.; Bianco, N.E.; Garmendia, J.V.; Rivas, L. Serum adipokine levels in patients with systemic lupus erythematosus. Autoimmunity 2009, 42, 272-274; doi:10.1080/08916930902828031.
29. Chung, C.P.; Long, A.G.; Solus, J.F.; Rho, Y.H.; Oeser, A.; Raggi, P.; Stein, C.M. Adipocytokines in systemic lupus erythematosus: Relationship to inflammation, insulin resistance and coronary atherosclerosis. Lupus 2009, 18, 799-806; doi:10.1177/0961203309103582.
30. Al, M.; Ng, L.; Tyrrell, P.; Bargman, J.; Bradley, T.; Silverman, E. Adipokines as novel biomarkers in paediatric systemic lupus erythematosus. Rheumatology 2009, 48, 497-501; doi:10.1093/rheumatology/kep030.
31. Vadacca, M.; Margiotta, D.; Rigon, A.; Cacciapaglia, F.; Coppolino, G.; Amoroso, A.; Afeltra, A. Adipokines and systemic lupus erythematosus: Relationship with metabolic syndrome and cardiovascular disease risk factors. J. Rheumatol. 2009, 36, 295-297; doi:10.3899/jrheum.080503.
32. McMahon, M.; Skaggs, B.J.; Sahakian. L.; Grossman, J.; FitzGerald, J.; Ragavendra, N.; Charles-Schoeman, C.; Chernishof, M.; Gorn, A.; Witztum, J.L.; et al. High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated wirth inflammatory oxidesed lipids. Ann. Rheum. Dis. 2011, 70, 1619-1624; doi:10.1136/ard.2010.142737.
33. Rovin, B.H.; Song, H.; Herbert, L.A.; Nadasdy, T.; Nadasdy, G.; Birmingham, D.J.; Yung, Y.C.; Nagaraja, H.N. Plasma, urine, and renal expression of adiponectin in human systemic lupus erythematosus. Kidney Int. 2005, 68, 1825-1833; doi:10.1111/j.1523-1755.2005.00601.x.
34. Ito, M.; Suganami, T.; Satoh, N.; Tanimoto-Koyama, K.; Yuan, X.; Tanaka, M.; Kawano, H.; Yano, T.; Aoe, S.; Takeya, M.; et al. Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects. Arterioscler. Thromb. Vasc. Biol. 2007, 27, 1918-1925; doi:10.1161/ATVBAHA.106.136853.
35. Shirai, N.; Suzuki, H. Effects of simultaneous intake of fish oil and green tea extracts on plasma, glucose, insulin, C-peptide, and adiponectin on liver lipid concentrations in mice fed low- and high-fat diets. Ann. Nutr. Metab. 2008, 52, 241-249; doi:10.1159/000140516.
36. Lara, J.J.; Economou, M.; Wallace, A.M.; Rumley, A.; Lowe, G.; Slater, C.; Caslake, M.; Sattar, N.; Lean, M.E. Benefits of salmon eating on traditional and novel vascular risk, factors in young, non-obese healthy subjects. Atherosclerosis 2007, 193, 213-221; doi:10.1016/j.atherosclerosis.2006.06.018.
37. Simão, A.N.C.; Lovozoy, M.A.B.; Bahls, L.D.; Morimoto, H.K.; Simão, T.N.C.; Matsuo, T.; Dichi, I. Blood pressure decrease with ingestion of a soy product (kinako) or fish oil in women with metabolic syndrome: Role of adiponectin and nitric oxide. Br. J. Nutr. 2012, 108, 1435-1442; doi:10.1017/S0007114511006921.
38. Tao, L.; Wang, Y.; Gao, E.; Zhang, H.; Yuan, Y.; Lau, W.B.; Chan, L.; Koch, W.J.; Ma, X.L. Adiponectin - An indispensable molecule in rosiglitazone cardioprotection following myocardial infarction. Circ. Res. 2010, 106, 409-417; doi:10.1161/CIRCRESAHA.109.211797.
39. Takemura, Y.; Ouchi, N.; Shibata, R.; Aprahamian, T.; Kirber, M.T.; Summer, R.S.; Kihara, S.; Walsh, K. Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearnace of early apoptotic bodies. J. Clin. Investig. 2007, 117, 375-386; doi:10.1172/JCI29709.
40. Li, S.; Sun, Y.; Liang, C.-P.; Thorp, E.B.; Han, S.; Jehle, A.W.; Saraswathi, V.; Pridgen, B.; Kanter, J.E.; Li, R.; et al. Defective phagocytosis of apoptotic cells by macrophages in atherosclerotic lesions of ob/ob mice by a fish oil diet. Circ. Res. 2009, 105, 1072-1082; doi:10.1161/CIRCRESAHA.109.199570.
41. Garcia-Gonzalez, A.; Gonzalez-Lopes, L.; Valera-Gonzalez, I.C.; Cardona-Muñoz, E.G.; Salazar-Paramo, M.; González-Ortiz, M.; Martínez-Abundis, E.; Gamez-Nava, J.I. Serum leptin levels in women with systemic lupus erythematosus. Rheumatol. Int. 2002, 22, 138-141; doi:10.1007/s00296-002-0216-9.
42. Lo, J.; Bernstein, E.; Canavan, B.; Torriani, M.; Jackson, M.B.; Ahima, R.S.; Grinspoon, S.K. Effects of TNF-α neutralization on adipocytokines and skeletal muscle adiposity in the metabolic syndrome. Am. J. Physiol. Endocrinol. Metab. 2007, 293, E102-E110; doi:10.1152/ajpendo.00089.2007.
43. Grimble, R.F.; Howell, W.M.; O'Reilly, G.; Turner, S.J.; Markovic, O.; Hirrell, S.; East, J.M.; Calder, P.C. The ability of fish oil to suppress tumor necrosis factor alpha production by peripheral blood mononuclear cells in healthy men is associated with polymorphisms in genes that influence tumor necrosis factor alpha production. Am. J. Clin. Nutr. 2002, 76, 454-459.
44. Zhu, W.; Cheng, K.K.Y.; Vanhoutte, P.M.; Lam, K.S.; Xu, A. Vascular effects of adiponectin: Molecular mechanisms and potential therapeutic intervention. Clin. Sci. 2008, 114, 361-374; doi:10.1042/CS20070347.